Cancer Genetics Prices Public Offering, Moves to Nasdaq | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics today announced the public offering of 1.5 million shares of its common stock at $10 per share and the migration of its stock to the Nasdaq Capital Market.

Its stock had been trading on the OTC QB since the company went public in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.